Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial

NCT00462995 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT00462995
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00462995 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial
Lead sponsor
University Health Network, Toronto
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2006
Completion date
February 29, 2012
Enrollment
25 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer